Professor silviu itescu biography for kids
Biography for 2nd graders...
Professor silviu itescu biography for kids
October 20, 2024
Mesoblast (NASDAQ:MESO) is an Australian biotech company that the Wall Street Transcript has been keeping in touch with for over 8 years.
Our latest interview with CEO Silviu Itescu, MBBS, FRACP, demonstrates the perseverance and intelligence needed for a novel medical treatment to succeed.
Silviu Itescu, CEO and Managing Director Mesoblast (NASDAQ:MESO)
Dr.
Itescu has served on Mesoblast’s board of directors since the company’s founding in 2004, was Executive Director from 2007, and became Chief Executive Officer and Managing Director in 2011.
Prior to founding Mesoblast in 2004, he established an international reputation as a physician scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation, and heart failure.
Dr.
Itescu has been a faculty member of Columbia University in New York, and the University of Melbourne and Monash University in Australia.
In 2013, Dr. Itescu received the inaugural Key Innovator Award from the V